Back to Trades
BRYNJELSEN SEAN
President & CEODirectorCIK 0001669976
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
BRYNJELSEN SEAN, President & CEO, Director, has filed 5 SEC reports (2025–2026), all concentrated in Eton Pharmaceuticals, Inc. (ETON), totaling $7.0M in disclosed volume. Weighing $0 bought versus $3.8M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Aug 4 | ETON Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO, Director | Award | $0 |
| Jul 14 | ETON Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO, Director | Exercise | $548.0K |
| May 29 | ETON Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO, Director | Sell | $3.8M |
| Jan 14 | ETON Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO, Director, 10% Owner | Award | $2.5M |
| Dec 12 | ETON Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO, Director, 10% Owner | Tax withheld | $113.3K |
5 filings